DIAGNOSIS OF ENDOCRINE DISEASE: Bone turnover markers: are they clinically useful?
Sign Up to like & getrecommendations! Published in 2018 at "European journal of endocrinology"
DOI: 10.1530/eje-17-0585
Abstract: Bone turnover markers (BTMs) are useful in clinical practice as they are inexpensive, and they have proven useful for treatment monitoring and identification of poor adherence. BTMs cannot be used in individual patients for identifying… read more here.
Keywords: anti resorptive; clinical practice; bone; bone turnover ... See more keywords
MANAGEMENT OF ENDOCRINE DISEASE: Atypical femoral fractures: risks and benefits of long-term treatment of osteoporosis with anti-resorptive therapy.
Sign Up to like & getrecommendations! Published in 2018 at "European journal of endocrinology"
DOI: 10.1530/eje-17-1002
Abstract: Modern osteoporosis treatment began in the mid-1990s with the approval of amino-bisphosphonates, anti-resorptive agents that have been shown to decrease osteoporotic fracture risk by about half. In 2005, the first cases of atypical femoral fractures… read more here.
Keywords: anti resorptive; femoral fractures; long term; management ... See more keywords
Aplidin (plitidepsin) is a novel anti-myeloma agent with potent anti-resorptive activity mediated by direct effects on osteoclasts
Sign Up to like & getrecommendations! Published in 2019 at "Oncotarget"
DOI: 10.18632/oncotarget.26831
Abstract: Despite recent progress in its treatment, Multiple Myeloma (MM) remains incurable and its associated bone disease persists even after complete remission. Thus, identification of new therapeutic agents that simultaneously suppress MM growth and protect bone… read more here.
Keywords: myeloma; potent anti; anti resorptive; bone ... See more keywords
Incidence and Risk of Anti-Resorptive Agent-Related Osteonecrosis of the Jaw after Tooth Extraction: A Retrospective Study
Sign Up to like & getrecommendations! Published in 2022 at "Healthcare"
DOI: 10.3390/healthcare10071332
Abstract: Bone-modifying agents (BMA) such as bisphosphonates and denosumab are frequently used for the treatment of bone metastases, osteoporosis, and multiple myeloma. BMA may lead to anti-resorptive agent-related osteonecrosis of the jaw (ARONJ). This study aimed… read more here.
Keywords: tooth extraction; anti resorptive; extraction; resorptive agent ... See more keywords
Bisphosphonates: from bone anti-resorptive to anti-cancer drugs.
Sign Up to like & getrecommendations! Published in 2017 at "Medical Oncology"
DOI: 10.35841/medical-oncology.2.1.20-23
Abstract: Bisphosphonates, analogues of pyrophosphates, are utilized as efficient drugs against bone resorption in bone disorders like, osteoporosis, Paget's disease, multiple myeloma, cancerinduced hypercalcemia, and bony metastases. They suppress osteoclastic bone resorption by incorporating with hydroxyapatite… read more here.
Keywords: resorptive anti; anti resorptive; bone; bone anti ... See more keywords